In the present study, we demonstrated that fluorescent anti-MUC4-IR800 can selectively target pancreatic cancers in orthotopic cell line mouse models compared to both normal pancreatic tissue and the liver. This evidence concerns the gene MUC4 and pancreatic neoplasm.